Genmab — Maj 2015
-
Godt gættet Solsen.
-
-
"Lonial said this was the first antibody drug that demonstrated effectiveness against
myeloma without having to be combined with other medicines". -
Super link Solsen.
-
-
-
En masse SE med HTF og en enkelt PR indtil videre
-
Dog også virkelig mange patienter med desease progression. Men det er også meget pretreated
-
Det skal jeg vidst have Novod og Bowers til at kigge på. Jeg kan ikke vurdere om det er godt .)
-
der kommer safety issues ved 2,2 mg. men ingenting ved 1,8 så de regner med at 2,0 bliver den valgte MTD
-
men det er også hvad man har set andre ADC stoffer anvende så vidt jeg ved, så ikke den store forskel der
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind